FIGS, Inc. (FIGS)

Verve Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	569.58	555.56	545.65	505.84	419.59	263.11
Revenue Growth (YoY)	3.41%	1.82%	7.87%	20.55%	59.47%	138.12%
Cost of Revenue	186.65	179.94	168.68	151.38	118.37	72.89
Gross Profit	382.93	375.62	376.96	354.46	301.22	190.22
Selling, General & Admin	372.96	373.36	342.92	316.79	290.24	132.28
Operating Expenses	372.96	373.36	342.92	316.79	290.24	132.28
Operating Income	9.97	2.27	34.05	37.67	10.98	57.94
Interest Expense	-	-	-	-	-0.24	-
Interest & Investment Income	9.76	11.24	6.78	1.71	-	0.14
Other Non Operating Income (Expenses)	0.84	0.83	-0.01	-0.65	-0.89	-
Pretax Income	20.57	14.34	40.81	38.73	9.86	58.08
Income Tax Expense	13.39	11.62	18.17	17.54	19.42	8.32
Net Income	7.18	2.72	22.64	21.19	-9.56	49.76
Net Income to Common	7.18	2.72	22.64	21.19	-9.56	49.76
Net Income Growth	-61.56%	-87.98%	6.85%	-	-	44326.79%
Shares Outstanding (Basic)	165	169	168	165	159	153
Shares Outstanding (Diluted)	177	180	182	188	159	163
Shares Change (YoY)	-2.32%	-1.27%	-2.74%	17.82%	-2.54%	6.32%
EPS (Basic)	0.04	0.02	0.13	0.13	-0.06	0.32
EPS (Diluted)	0.04	0.02	0.12	0.11	-0.06	0.30
EPS Growth	-52.00%	-86.60%	9.09%	-	-	41052.13%
Free Cash Flow	39.88	64.14	84.57	-40.68	63.73	19.49
Free Cash Flow Per Share	0.23	0.36	0.46	-0.22	0.40	0.12
Gross Margin	67.23%	67.61%	69.09%	70.07%	71.79%	72.30%
Operating Margin	1.75%	0.41%	6.24%	7.45%	2.62%	22.02%
Profit Margin	1.26%	0.49%	4.15%	4.19%	-2.28%	18.91%
Free Cash Flow Margin	7.00%	11.54%	15.50%	-8.04%	15.19%	7.41%
EBITDA	18.86	8.96	36.99	39.59	12.41	58.89
EBITDA Margin	3.31%	1.61%	6.78%	7.83%	2.96%	22.38%
D&A For EBITDA	8.88	6.69	2.94	1.92	1.42	0.95
EBIT	9.97	2.27	34.05	37.67	10.98	57.94
EBIT Margin	1.75%	0.41%	6.24%	7.45%	2.62%	22.02%
Effective Tax Rate	65.09%	81.03%	44.53%	45.29%	196.93%	14.32%

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q